Clinical Evidence Based and TCM Phenotype Group Study of Zhilong Huoxue Tongyu Capsule in the Treatment of Stable Angina Pectoris of Coronary Heart Disease (Qi Deficiency and Blood Stasis Syndrome)

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

230

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Coronary Heart Disease (CHD)

Interventions

OTHER

Placebo Comparator

DRUG

Zhilong Huoxue Tongyu capsule

Trial Locations (1)

Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University, Luzhou

All Listed Sponsors

lead

Jiang Hanmei

OTHER